510(k) K240197

cobas® liat CT/NG/MG nucleic acid test by Roche Molecular Systems, Inc. — Product Code QEP

K240197 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas® liat CT/NG/MG nucleic acid test". The FDA issued a decision of Substantially Equivalent on Jan 16, 2025. The device falls under product code QEP (Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections), a Class II device regulated under 21 CFR 866.3393. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 16, 2025
Date Received
Jan 25, 2024
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections
Device Class
Class II
Regulation Number
866.3393
Review Panel
MI
Submission Type
510(k)

A device to detect nucleic acids from non-viral microorganism(s) causing sexually transmitted infections is an in vitro diagnostic device intended for the detection and identification of nucleic acids from non-viral microorganism(s) in clinical specimens collected from patients suspected of sexually transmitted infections. The device is intended to aid in the diagnosis of non-viral sexually transmitted infections in conjunction with other clinical and laboratory data.

Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K240197. Report a data issue: hello@regdatalab.com.